AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Profusa Announces New Collaboration with AZ Sint Blasius Hospital in Belgium.
ByAinvest
Thursday, Sep 4, 2025 8:33 am ET1min read
Profusa announces a new commercial and clinical collaboration with AZ Sint Blasius Hospital in Belgium, led by internationally recognized vascular surgeon Dr. Koen Deloose. The collaboration aims to provide patients with access to innovative treatments and personalized care. Dr. Deloose has extensive experience in treating critical limb ischemia and has treated over 300 patients annually. The collaboration aims to promote Profusa's digital health technology platform, enabling continuous monitoring of an individual's biochemistry.
Profusa, a leading digital health technology company, has announced a new commercial and clinical collaboration with AZ Sint Blasius Hospital in Belgium. The partnership is led by Dr. Koen Deloose, an internationally recognized vascular surgeon with extensive experience in treating critical limb ischemia. The collaboration aims to provide patients with access to innovative treatments and personalized care, leveraging Profusa's digital health technology platform for continuous monitoring of biochemistry.The collaboration, announced on September 2, 2025, marks a significant milestone in Profusa's efforts to promote its digital health technology. The platform enables continuous monitoring of an individual's biochemistry, which can significantly improve patient outcomes and reduce healthcare costs. Dr. Deloose has treated over 300 patients annually, and his expertise in treating critical limb ischemia will be instrumental in the successful implementation of the digital health technology at AZ Sint Blasius Hospital.
The collaboration is expected to enhance Profusa's market position in the digital health sector, which is projected to grow at a CAGR of 15.4% from 2021 to 2028 [1]. By partnering with a renowned hospital like AZ Sint Blasius, Profusa can demonstrate the real-world effectiveness of its technology and attract more investors and partners.
Profusa's digital health technology platform has the potential to revolutionize the way healthcare is delivered. By continuously monitoring patients' biochemistry, healthcare providers can detect and address health issues early, leading to better patient outcomes and reduced healthcare costs. The collaboration with AZ Sint Blasius Hospital is a step towards realizing this potential.
References:
[1] https://www.globenewswire.com/news-release/2025/09/03/3143441/30038/en/SINTX-Technologies-Publishes-Landmark-Study-Demonstrating-Broad-Spectrum-Antiviral-Activity-of-Silicon-Nitride.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet